[{"Assets_0_Q2_USD":106478000.0,"CommonStockSharesOutstanding_0_Q2_shares":75000000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-2905000.0,"NetIncomeLoss_1_Q2_USD":-12833000.0,"NetIncomeLoss_2_Q2_USD":-18014000.0,"StockholdersEquity_0_Q2_USD":35234000.0,"Ticker":"TLRY","CIK":"1731348","name":"TILRAY, INC.","OfficialName":"Tilray Brands Inc. Class 2 Common Stock ","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2601094383.0","Country":"Canada","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180829"}]